Biotest AG
BIESFOTCHealthcare
$32.00
+$0.00(+0.00%)
Market Cap$1.6B
P/E Ratio—
52W High$32
52W Low$30.48
Biotest AG（BIESF）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · BIESF · 截至 Jun 8, 2026
关键指标
探索 Biotest AG 数据
biesf stock data · financials财务快照
完整财报FY 2024Revenue$726.2M▲ +6.08% YoY
202220232024
biotest ag revenue · biesf revenue 2024FY 2024Net Income$26.4M▼ 79.21% YoY
202220232024
biotest ag net income · biesf profit 2024FY 2024EPS$0.71▼ 77.88% YoY
202220232024
biesf eps · biotest ag earnings per share 2024竞争对手与同行
biesf competitors#TickerCompanyPriceChangeMkt Cap
#1BIESFBiotest AG
$32.00+0.00%$1.6B#2
BITGFBiotage AB (publ)
$15.01+0.00%$1.2B#3
CKDXFOpthea Limited
$0.44+0.00%$601.9M#4
CMPUYCompuGroup Medical SE & Co. KGaA
$23.00-7.26%$1.2B#5
CMPVFCompuGroup Medical SE & Co. KGaA
$33.66+11.64%$1.7B#6
DWRKFDrägerwerk AG & Co. KGaA
$543.70+0.00%$1.8B股票表现
完整历史1D+0.00%
1W+0.00%
1M+0.00%
3M+0.00%
YTD+4.99%
1Y+4.99%
5Y+43.43%
关于 Biotest AG
Biotest AG Biotest Aktiengesellschaft develops, manufactures, and sells biological medicines in Germany and internationally. It operates through Therapy, Plasma & Services, and Other segments. The company offers…
what is biotest ag · biesf stock overview · biotest ag company profile · who is biotest ag ceo · biesf OTC · biotest ag headquarters · biotest ag business segments
关于股票概览与关键数据
Biotest AG（BIESF）是 Biotechnology 行业的 Healthcare 类公司，于 Jan 9, 2014 在 OTC 上市。截至最近交易日，BIESF 股价为 $32.00，市值约为 $1.6B。过去12个月累计回报 +4.99%，年初至今回报 +4.99%。
2024 财年 Biotest AG 营收 $726.2M。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Biotest AG（BIESF）股价为 $32.00，在 OTC 上市，52周区间为 $30.48 – $32.00。
BIESF 最新股价BIESF quote todaylive ticker 实时行情
数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议